JCHO東京山手メディカルセンターは、東京都新宿区百人町にある医療機関。独立行政法人地域医療機能推進機構が運営する病院である。

During the past decade, JHCO Tokyo Yamate Medical Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JHCO Tokyo Yamate Medical Center" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "Takeda" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JHCO Tokyo Yamate Medical Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "JHCO Tokyo Yamate Medical Center" are "Ulcerative Colitis" (12 trials), "Crohn's Disease" (9 trials), "Colitis, Ulcerative" (3 trials), "Atrial Fibrillation" (1 trials) and "Fistulizing Crohns Disease" (1 trials). Many other conditions were trialed in "JHCO Tokyo Yamate Medical Center" in a lesser frequency.

Most popular intervention types in "JHCO Tokyo Yamate Medical Center" are "Drug" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Etrasimod" (5 trials), "Mirikizumab" (5 trials), "Filgotinib" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "JHCO Tokyo Yamate Medical Center" are 25 trials for "All" genders.

Currently, there are NaN active trials in "JHCO Tokyo Yamate Medical Center". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in JHCO Tokyo Yamate Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in JHCO Tokyo Yamate Medical Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".